Pfizer’s Financial Resilience Amid Challenges
Pfizer Inc, a global pharmaceutical leader, has filed its 10-Q report, revealing a mix of financial resilience and challenges. Despite a slight decrease in total revenues ($45,022 million vs $45,864 million), the company reported robust net income ($9,419 million) and demonstrated market leadership with a diverse product portfolio. The strengths of Pfizer’s financial health include: … Read more